Primary Record
Dapagliflozin
- In stock
- 6,778 g
- Purity
- 98.1 %
- CAS
- 461432-26-8
Compound Identifiers & Properties
- CAS
- 461432-26-8
- PubChem CID
- 9887712
- SMILES
- CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)Cl
- Canonical SMILES
- CCOc1ccc(Cc2cc([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc2Cl)cc1
Names & Synonyms
- Dapagliflozin
- 461432-26-8
- Forxiga
- Farxiga
- dapagliflozine
- BMS-512148
- Dapagliflozina
- Dagagflozin
- dapagliflozinum
- dapaglifozin
- Dapagliflozin [USAN]
- Forxiga (TN)
- 1ULL0QJ8UC
- DAPAGLIFLOZIN?
- S1548_Selleck
- C-aryl glucoside, 6
- UNII-1ULL0QJ8UC
- BMS 512148
- Tube101
- Dapagliflozin propanediol
- RefChem:54930
- Dapagliflozin (Standard)
- Dapagliflozin [USAN:INN]
- DAPAGLIFLOZIN [MI]
- MFCD13182359
- D01TNW
- DAPAGLIFLOZIN [INN]
- Dapagliflozin (INN/USAN)
- LYN-045
- CHEMBL429910
- BMS512148
- C21H25ClO6
- DAPAGLIFLOZIN [VANDF]
- cc-205
- CHEBI:85078
- Dapagliflozin/BMS-512148
- SCHEMBL157820
- DTXSID20905104
- DAPAGLIFLOZIN [WHO-DD]
- BMS-512148, Dapagliflozin
- GLU006
- GTPL4594
- orb1305553
- orb3012985
- BR1019 component Dapagliflozin
- CHEMBL3125316
- CHEMBL3125317
- CHEMBL3125318
- CHEMBL3125455
- CHEMBL3125456
- CHEMBL3125457
- CHEMBL3125458
- Dapagliflozin (JAN/USAN/INN)
- SCHEMBL29364603
- BDBM20880
- A10BK01
- EX-A005
- Dapagliflozin - Bio-X trade mark
- JVHXJTBJCFBINQ-ADAARDCZSA-N
- BCPP000265
- DTXCID101334207
- GLXC-90177
- DAPAGLIFLOZIN [ORANGE BOOK]
- DAPAGLIFLOZIN COMPONENT QTERNMET
- AMX10145
- AMY18541
- AOB87300
- dapagliflozin propanediol monohydrate
- KS-000006UW
- MSK11068
- ZINC3819138
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- AN-431
- BDBM50448923
- CD0219
- EBC-11348
- HY-10450R
- s1548
- QTERNMET COMPONENT DAPAGLIFOZIN
- AKOS005145763
- QTERNMET XR COMPONENT DAPAGLIFLOZIN
- ACN-028597
- BCP9000583
- BL-0052
- BMS5121458
- CCG-229917
- CID9887712
- CS-0781
- CS-O-11248
- DB06292
- EX-7214
- MD20795
- RL03723
- Dapagliflozin propylene glycolate hydrate
- NCGC00250402-09
- AC-24699
- AJ-45726
- BD164346
- HY-10450
- SC-25116
- SY028092
- AB1008441
- (2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol
- 5168A
- A5854
- NS00099173
- ST24046416
- J2.928.717A
- A10285
- A25150
- C22193
- D08897
- Q-3845
- EN300-7407160
- 432D268
- Q409898
- BRD-K58160573-001-01-3
- BRD-K58160573-001-04-7
- BRD-K58160573-001-05-4
- Z2235801883
- B0084-069214
- BMS-512148, 461432-26-8
- D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-
- (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- 1-[3-(beta-D-Glucopyranosyl)-6-chlorobenzyl]-4-ethoxybenzene
- 1-[3-(4-Ethoxybenzyl)-4-chlorophenyl]-1-deoxy-beta-D-glucopyranose
- 1-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1-deoxy-beta-D-glucopyranose
- 2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
- D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-
- (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
- (2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- 960404-48-2
- (1S)-1,5-Anhydro-1-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-D-glucitol
- (1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; BMS 512148; Dapagliflozin; Farxiga
- (2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol
- (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- 639-683-0
- LE6